Indication
Fungal infection of lung
A fungal infection of the lung, or pulmonary mycosis, is a lower respiratory tract disease caused by the inhalation and subsequent proliferation of environmental fungal spores within the pulmonary parenchyma or airways. Read more about Fungal infection of lung
3 drugs 3 manufacturers
Drugs that treat it
Common Fungal infection of lung therapies.
ABELCET (amphotericin B lipid complex)
ABELCET (amphotericin B lipid complex)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA fungal infection of the lung, or pulmonary mycosis, is a lower respiratory tract disease caused by the inhalation and subsequent proliferation of environmental fungal spores within the pulmonary parenchyma or airways.
It affects both immunocompetent individuals exposed to geographically endemic dimorphic fungi—such as *Histoplasma*, *Coccidioides*, or *Blastomyces*—and immunocompromised or chronically ill patients susceptible to opportunistic pathogens, including *Aspergillus*, *Pneumocystis jirovecii*, and *Cryptococcus*.
Pathophysiologically, the condition is characterized by alveolar and interstitial inflammation, granuloma formation, tissue necrosis, or angioinvasion leading to cavitation and pulmonary infarction.
Manifestations range from asymptomatic colonization and subacute pneumonia to severe, life-threatening respiratory failure marked by fever, cough, chest pain, dyspnea, and hemoptysis.
- nih.gov
A fungal infection of the lung, or pulmonary mycosis, is a lower respiratory tract disease caused by the inhalation and subsequent proliferation of environmental fungal spores within the pulmonary parenchyma or airways It affects both immunocompetent individuals exposed to geographically endemic dimorphic fungi—such as *Histoplasma*, *Coccidioides*, or *Blastomyces*—and immunocompromised or chronically ill patients susceptible to opportunistic pathogens, including *Aspergillus*, *Pneumocystis ji...
- cdc.gov
A fungal infection of the lung, or pulmonary mycosis, is a lower respiratory tract disease caused by the inhalation and subsequent proliferation of environmental fungal spores within the pulmonary parenchyma or airways Manifestations range from asymptomatic colonization and subacute pneumonia to severe, life-threatening respiratory failure marked by fever, cough, chest pain, dyspnea, and hemoptysis
- youtube.com
A fungal infection of the lung, or pulmonary mycosis, is a lower respiratory tract disease caused by the inhalation and subsequent proliferation of environmental fungal spores within the pulmonary parenchyma or airways It affects both immunocompetent individuals exposed to geographically endemic dimorphic fungi—such as *Histoplasma*, *Coccidioides*, or *Blastomyces*—and immunocompromised or chronically ill patients susceptible to opportunistic pathogens, including *Aspergillus*, *Pneumocystis ji...
- nih.gov
It affects both immunocompetent individuals exposed to geographically endemic dimorphic fungi—such as *Histoplasma*, *Coccidioides*, or *Blastomyces*—and immunocompromised or chronically ill patients susceptible to opportunistic pathogens, including *Aspergillus*, *Pneumocystis jirovecii*, and *Cryptococcus*
- nih.gov
It affects both immunocompetent individuals exposed to geographically endemic dimorphic fungi—such as *Histoplasma*, *Coccidioides*, or *Blastomyces*—and immunocompromised or chronically ill patients susceptible to opportunistic pathogens, including *Aspergillus*, *Pneumocystis jirovecii*, and *Cryptococcus* Manifestations range from asymptomatic colonization and subacute pneumonia to severe, life-threatening respiratory failure marked by fever, cough, chest pain, dyspnea, and hemoptysis
- nih.gov
It affects both immunocompetent individuals exposed to geographically endemic dimorphic fungi—such as *Histoplasma*, *Coccidioides*, or *Blastomyces*—and immunocompromised or chronically ill patients susceptible to opportunistic pathogens, including *Aspergillus*, *Pneumocystis jirovecii*, and *Cryptococcus*
- cdc.gov
Pathophysiologically, the condition is characterized by alveolar and interstitial inflammation, granuloma formation, tissue necrosis, or angioinvasion leading to cavitation and pulmonary infarction
Personalize your experience
Follow Fungal infection of lung and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.